Regulatory Open Forum

 View Only
Expand all | Collapse all

Input needed from MDR gurus!

  • 1.  Input needed from MDR gurus!

    Posted 16-Jan-2020 19:09
    Edited by Julie Omohundro 17-Jan-2020 11:26
    I'm trying to work out a high-level look at the impact the MDR is likely to have on the number of medical devices on the EU market before and after May 26.  Here's what I have so far.  I would be happy to have any corrections, additions, suggestions, or other comments from some of the MDR gurus here might offer, as I am not one:

    Expiration and Renewal Timeframes for MDD-Certified Class II-III Medical Devices

    MDD Certified
    Class II-III Devices

    Issued

     Expiration

    Renewable

    Expiring

    Group A (20%)

    May 27 2012 to May 26 2013

    May 26 2017 to May 25 2018

    May 27 2017 to May 26 2018

    May 26 2022 to May 25 2023

    Group B (20%)

    May 27 2013 to May 26 2014

    May 26 2018 to May 25 2019

    May 27 2018 to May 26 2019

    May 26 2023 to May 25 2024

    Group C (20%)

    May 27 2014 to May 26 2015

    May 26 2019 to May 25 2020

    May 27 2019 to May 26 2020

    May 26 2024 to May 25 2025

    Group D (20%)

    May 27 2015 to May 26 2016

    May 26 2020 to May 25 2021

    No

     

    Group E (20%)

    May 27 2016 to May 26 2017

    May 26 2021 to May 25 2022

    No

     

    Groups A and B

    These devices are in one of two situations:

    1. The NB that issued their MDD certificates will continue to provide NB services through the transition. In this case, these devices can remain on the EU market without an MDR-designated NB for another 2-4 years. They must still conform to the requirements of the MDR.
    2. The NB that issued their MDD certificates will not continue to provide NB services through the transition. Apparently the main determinant here is whether their medical device staff think that their employer will eventually be MDR-designated. If not, they are prone to a sudden desire to seek their future elsewhere, leaving no one left to provide the services.


    According to the October 2019 Joint Assessments Report, 40 notified bodies have sought designation under the MDR.  As of now, 9 have been designated.  Whether any of the remaining 31 will fail to secure designation is unknown, but it seems probable that these 40 NBs were still renewing MDD certificates through May 25 2019 and that their staff feel no pressing need to seek employment elsewhere, so they currently are expecting to offer MDD services through the transition. 

    Therefore, as of now, most of the devices in Groups A and B will apparently be able to ride their MDD certificates through at least May 26 2022.

    Group C

    These devices give new meaning to being "at an awkward age."  If their manufacturers were very forward looking, they renewed their MDD certifications early, which puts them in the same position as the devices in Groups A and B.  But probably few of their manufacturers expected NB capacity to get this tight, so they probably decided they would forego renewal for these devices and pursue MDR designation instead. Oops. Some of these devices--those that had MDD certification from an NB that secured MDR designation in 2019--will get MDR certification by May 26, but the majority will probably still be waiting in queue.

    Groups D and E

    None of the devices in these groups can ride their MDD certificates past May 26, so their manufacturers should have started to prepare early.  Those that were fortunate enough to hold MDD certificates from one of the NBs that were certified in 2019 should be well positioned to get their certificates by May 26, or shortly enough thereafter so as not to be a huge problem. The same is true for a small percentage holding MDD certificates from NBs certified in early 2020.  The rest will probably get MDR certificates sometime in 2020…IF the NB that holds their MDD certificates gets MDR designated.



    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------


  • 2.  RE: Input needed from MDR gurus!

    Posted 16-Jan-2020 19:32
    You start in a hole because there are no Class II devices in the EU. the device classes are I, IIa, IIb, and III.


    ------------------------------
    Dan O'Leary CQA, CQE
    Swanzey NH
    United States
    ------------------------------



  • 3.  RE: Input needed from MDR gurus!

    Posted 16-Jan-2020 20:30
    Yes, I am using Class II-III as a range, not a list.

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 4.  RE: Input needed from MDR gurus!

    Posted 16-Jan-2020 19:59

    I should have added that there are only three states for a given device.

     

    It meets the requirements under the MDD/AIMD

     

    It is an EU-MDR Article 120 device (some MDD/AIMD and some MDR)

     

    It is an EU-MDR device

     

    There are also three states for an NB

     

    Designated under the MDD/AIMD and supports Article 120

     

    Designated under the MDD/AIMD and does not support Article 120

     

    Designated under the MDR

     

    It would seem that there are 3 × 3 = 9 states. However, there are Class I devices that don't need an NB under MDD and Class I devices that don't need an NB under MDR. The set of Class I devices is not the same in both cases.



    ------------------------------
    Dan O'Leary CQA, CQE
    Swanzey NH
    United States
    ------------------------------



  • 5.  RE: Input needed from MDR gurus!

    Posted 16-Jan-2020 20:43

    I should have added that the classification of a device may change from the MDD to the MDR. Because each has four device classes, there are 16 combinations



    ------------------------------
    Dan O'Leary CQA, CQE
    Swanzey NH
    United States
    ------------------------------



  • 6.  RE: Input needed from MDR gurus!

    Posted 16-Jan-2020 21:29
    Thanks for your input, Dan. 

    In this case, I'm looking at things from the perspective of what determines whether or not they are likely to be on the market after May 26.  I don't think changes in device class are likely to have a major impact on MDD Class II-III devices from that perspective, because I think virtually all of the Class II-III devices currently certified under the MDD will need an NB to stay on the EU market after May 26.

    I haven't gotten to Class I devices yet.

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 7.  RE: Input needed from MDR gurus!

    Posted 17-Jan-2020 09:29
    Hi Julie,

    when you come to consider the Class I devices please be aware that Article 120(3) was changed recently. The new wording is a bit confusing so if you need help just ask.

    Best regards

    ------------------------------
    Kevin Painter
    Mentor, Medical Device Regulatory Compliance
    Poland and United Kingdom
    ------------------------------



  • 8.  RE: Input needed from MDR gurus!

    Posted 17-Jan-2020 09:44
    https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745R%2802%29

    ------------------------------
    Kevin Painter
    Mentor, Medical Device Regulatory Compliance
    Poland and United Kingdom
    ------------------------------



  • 9.  RE: Input needed from MDR gurus!

    Posted 17-Jan-2020 11:16
    Thanks, Kevin.  As far as I can tell, the whole darn thing is more than a bit confusing. :)

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 10.  RE: Input needed from MDR gurus!

    Posted 17-Jan-2020 16:19
    only Art. 120 is confusing or the whole darn regulation? :)
    Article 120(3) is a contingency against sufficient notified bodies not being available. 
    Any legacy MDD device that requires notified body review under the MDR can take advantage of this (conditional) transition period, as long it is MDD compliant on 26th May. MDD compliant means either it has an MDD notified body certificate or, in the case of Class I devices which are up-classified by the MDR (e.g. many software devices), an MDD Declaration of Conformity.


    Best regards


    ------------------------------
    Kevin Painter
    Mentor, Medical Device Regulatory Compliance
    Poland and United Kingdom
    ------------------------------



  • 11.  RE: Input needed from MDR gurus!

    Posted 18-Jan-2020 16:15
    The whole darn regulation!

    It was my impression that very few Class I device which were up-classified by the MDR had an MDD Declaration of Conformity, especially the software devices?

    Also, did you mean to say "as long as it is MDR compliant on May 26"?

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 12.  RE: Input needed from MDR gurus!

    Posted 19-Jan-2020 09:46

    Hi Julie,

    any device that is legitimately on the EU market today, including Class I devices, must have an MDD DofC (unless it already has an MDR EU DofC which is pretty rare).

    No, I intended what I wrote. "…as long as it is MDR compliant on May 26".

    Private message me if you want to talk on the phone. It might be easier.

    Best regards  



    ------------------------------
    Kevin Painter
    Mentor, Medical Device Regulatory Compliance
    Poland and United Kingdom
    ------------------------------



  • 13.  RE: Input needed from MDR gurus!

    Posted 20-Jan-2020 12:07
    So now I have some specific high-level questions:

    Does my logic seem to be on target?

    Can anyone think of any reason why a lot of Class I devices should come off the EU market May 26?  It seem to me that most of them will be largely unaffected by this date.

    Does anyone have any insights that might contradict the notion that innovative medical devices are dead in the EU?  I have looked at this several ways, and I keep coming back to my expectation that the MDR-designated NBs will not be inclined to want startups as clients.  Can anyone think of a reason that they would?


    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 14.  RE: Input needed from MDR gurus!

    Posted 20-Jan-2020 16:12
    Hi Julie, it's not that bad.

    Simple Class I devices (by simple I mean not sterile, not software, not measuring) were self certified under the MDD and are self certified  under MDR. Manufacturers have had 3 years to update their technical documents and QMS. But in my experience it hasn't been that difficult. 

    For any device that needs a notified body under MDR, manufactures have up to another four years in which they can market their MDD devices. Sure, they had to extend their MDD certificates, upgrade their vigilance system and implement a PMS system to qualify for the extra years. But again, wasn't too difficult.

    But for any new devices... I agree. I would launch in US and the rest of world for a couple of years until the dust settles in the EU. But as to why the EU is doing this.. just watch "The Bleeding Edge" on Netflix.

    Best regards. 


    ------------------------------
    Kevin Painter
    Mentor, Medical Device Regulatory Compliance
    Poland and United Kingdom
    ------------------------------



  • 15.  RE: Input needed from MDR gurus!

    Posted 20-Jan-2020 18:44
    Edited by Julie Omohundro 23-Jan-2020 01:26

    That's what I thought. But you know, if it sounds to good to be true...  So I have wondered if my bias was coloring my judgment.

    As for watching "Bleeding Edge"…never have, never will.  Don't get me started.  Seriously.

    As for what inspired the MDR/IVDR, I will never know, but history says that what creates the political will, and the use that is ultimately made of it, are often two very different things, not infrequently, diametrically opposed.  If it were actually possible to find out, I'd be comfortable putting down a sizeable bet that the new regulations turn out to have been driven by the large device manufacturers and NBs, since theirs are the interests that appear to be best served.  I think they could actually be pretty good for patients, too, but that is yet to be seen, and certainly not guaranteed   Whether the EC understood what it was doing, why, and the consequences...in these situations, that's always the big mystery to me.



    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 16.  RE: Input needed from MDR gurus!

    Posted 21-Jan-2020 02:03
    Julie

    The reason for the Class I devices coming off the market was that if they were up-classified they would need a CE cert from day 1 - and most don't because of the paucity of NB options.  That has been fixed with the recent change, allowing devices already marketed in Europe to continue to be marketed until 2024. allowing time to get a CE MDR.  Evidence of prior marketing can be an existing MDD CE cert (required for I(s) and I(m) devices), or a self certified DofC for Class I.  All self certifed devices are required to be backed by a Tech File and DofC.

    As for innovative devices, for sure that's exactly the problem.  New entrants will have no relationship with a Notified Body and they have all closed their doors to new clients  for the next couple of years.  See this blog...  https://brandwoodckc.com/the-door-to-europe-is-closed-where-else-should-i-look/ where I say:  "Put bluntly, while the rest of the world implements priority regulatory pathways for new technologies, Europe is closed for innovation."

    ------------------------------
    Arthur Brandwood PhD FRAPS
    Director and Principal Consultant
    Brandwood CKC
    Sydney, Australia
    Arthur.brandwood@brandwoodckc.com
    ------------------------------



  • 17.  RE: Input needed from MDR gurus!

    Posted 21-Jan-2020 13:53
    Edited by Julie Omohundro 21-Jan-2020 13:54

    Thanks, Arthur.  Starting to get a little clearer on Class I devices. 

    Other than Class1 resuable and Class I software devices, are you aware of of any sizable group of up-classified devices that were self-certified under the MDD and will eventually need an MDR-designated NB?

    So far the consensus seems to be that "software device" in this specific context (MDR up-classification) includes devices controlled by software, devices with embedded software, and SaMDs.  Do you agree?

    As for the innovative devices, that's the only way I have been able to see this playing out.  I have no clue whether the EC understood that this would be the result, or, if it did, whether it wanted this result, or it just didn't care.  If it didn't care, was it just a coincidence, or did someone actively push for it? 

    It's like the murder mystery of the medical device world...who killed innovative devices in the EU?  And why?

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 18.  RE: Input needed from MDR gurus!

    Posted 21-Jan-2020 16:29
    On further thought, it's probably innovative startups, not innovative devices, that are mostly dead.  I can't think of any reason that established device companies won't be able to introduce innovative devices, once the current certification rush is over

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 19.  RE: Input needed from MDR gurus!

    Posted 22-Jan-2020 11:35

    Hi Julie,

    Interesting you mention start-ups. For the past two years I've been mentoring at two start-up accelerators in Berlin, Germany. The majority of ideas involved using software so the pressure has been on them to be CE marked according to MDD by May. Just being self declared class I was enough to be able to take advantage of the transition period. All the projects I am aware of managed to do it.



    ------------------------------
    Kevin Painter
    Mentor, Medical Device Regulatory Compliance
    Poland and United Kingdom
    ------------------------------



  • 20.  RE: Input needed from MDR gurus!

    Posted 22-Jan-2020 13:53
    I am as interested to see how this all actually plays out as anyone.  As of now, however I wouldn't expect startups to disappear on May 26.  Those that have committed funding will at least get a chance to spend it.  Those that don't have funding locked down may find soon find that investors have started to look elsewhere.

    The environment may be somewhat different in the EU, but in general, I think innovative self-certified Class I devices will start to have a difficult time attracting investors. As you have noted, most involve software and, without software for "the buzz," most of these devices will be hard to pitch as ventures that will get anyone rich quick, and that is pretty much the whole point for most medical device investors.

    Startups that need an NB will probably not be able to get one.  I don't mean just by May 26; I mean ever. Not clear on how many unsavvy investors might still be parted from their money in the near term, without realizing that NBs don't have to take a company on as a client if they don't want to.  In any case, if startups can't get an NB, word will get around, sooner or later,  And then...I think...it's over.

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 21.  RE: Input needed from MDR gurus!

    Posted 23-Jan-2020 16:01

    OK, one more clarification would be appreciated!  Are there ANY devices...of ANY type or classification...that DO NOT have to conform to the MDR as of May 26?  Various devices are being given more time to get a certificate, but at least some still have to otherwise conform to the MDR as of May 26, right?  Are there any that do not?  (Other than IVDs, of course!!!)

    Can someone PLEASE clear this up?

    Thanks...



    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 22.  RE: Input needed from MDR gurus!

    Posted 24-Jan-2020 04:23
    Hi Kevin, your statement ​'Just being self declared class I was enough to be able to take advantage of the transition period' is not entirely correct.
    Class I products (under MDD) of which the classification under the MDR remains the same cannot make use of the transitional provisions of article 120 because they do not have a CE certificate which is a pre-requisite for the use of article 120. Only when a class I product (under MDD) requires the involvement of a Notified Body under MDR (upclassification) they may be placed on the market until 26 May 2024 when the requirements of article 120 are met - As stated in Corrigendum 2.

    Regarding the conformance of products Dan O'Leary puts it like this:
    1. It meets the requirements under the MDD/AIMD
    2. It is an EU-MDR Article 120 device
    3. It is an EU-MDR device
    As of 27 May 2020 the first state cannot be claimed anymore; the second state is piggy-bagging on a valid MDD CE-certificate under the restrictions and obligations of MDR article 120(3) and the third state being in full compliance with MDR.
    Its my opinion that after 26 May 2020 there are no MDD compliant devices anymore, only state 1 and state 2 MDR compliant products. The Declaration of Conformity should show which of both states is claimed, meaning that all DoCs have to be updated before 27 May 2020.

    Regarding the state of the Notified Bodies they (should) mimic above mentioned states, although I have not yet seen a designation of a Notified Body under article 120!? What happens if a Notified Body is not designated for MDR in time? Are they allowed to monitor the manufacturers and their products after 26 May 2020? Does somebody have information on this?

    ------------------------------
    Peter Reijntjes
    Principal Consultant Regulatory & Quality Affairs
    Arnhem
    Netherlands
    ------------------------------



  • 23.  RE: Input needed from MDR gurus!

    Posted 24-Jan-2020 08:43

    You ask, "Regarding the state of the Notified Bodies they (should) mimic above mentioned states, although I have not yet seen a designation of a Notified Body under article 120!? What happens if a Notified Body is not designated for MDR in time? Are they allowed to monitor the manufacturers and their products after 26 May 2020? Does somebody have information on this?"

    The NBs do not get separate recognition for MDR Article 120. They operate under the MDD, so an NB without an MDR designation can still handle devices under Article 120.

    In my analysis a device, not a manufacturer nor an NB, can be in one of three states:
    Under full MDD
    Under MDD as modified by MDR Article 120
    Under full MDR

    For the first two cases the NB must be designated for the MDD. For the third case the NB must be designated for the MDR.



    ------------------------------
    Dan O'Leary CQA, CQE
    Swanzey NH
    United States
    ------------------------------



  • 24.  RE: Input needed from MDR gurus!

    Posted 24-Jan-2020 09:50
    That is a way of looking at it​, let me put it forward the other way around.
    After the date of application of the MDR the MDD is also declared void (or other terminology) and for medical devices only the MDR is applicable. As an 'escape' the transitional provisions have been identified. A manufacturer uses the Declaration of Conformity to declare compliance with MDR art. 120 and makes reference to the applicable (MDD) CE-certificate. So far so good.

    I know that you suggested the same thing on the DoC, but the other way around; I think is not possible to claim compliance to a Directive which is void. However I think one can claim compliance to the requirements of that void Directive via compliance with MDR article 120. I know this is not stated as such in art 120(3).

    Another thing is:
    Article 120(3) also states that 'Without prejudice to Chapter IV and paragraph 1 of this Article, the notified body that issued the certificate referred to in the first subparagraph shall continue to be responsible for the appropriate surveillance in respect of all of the applicable requirements relating to the devices it has certified.'

    My question/uncertainty is how can a Notified Body still be notified for a Directive that has become void? I do not think that it is possible.
    And how can a Notified Body, not yet or not at all been designated for the MDR in time, assess the implementation of all the applicable the requirements in MDR article 120(3) in an appropriate way when they have not been assessed and approved to do so?
    This whole article 120 seems to be legally rather shaky and unclear to me. It puzzles me.

    And this is not the only issue in the MDR which puzzles me...…. :-)

    ------------------------------
    Peter Reijntjes
    Principal Consultant Regulatory & Quality Affairs
    Arnhem
    Netherlands
    ------------------------------



  • 25.  RE: Input needed from MDR gurus!

    Posted 24-Jan-2020 11:03
    I love it how we all beat these definitions to death, when we are not the ones who get to implement them.  I wonder if the NBs put in half as much effort, lol.

    If it will help, I agree that, logically, a Notified Body cannot still be notified for a Directive that has become void.  But that's not what the language you quoted says.  It says "the notified body that issued the certificate."  The fact that it is no longer a Notified Body strikes me as irrelevant. 

    I also don't think it has to still be a Notified Body in order to continue to be responsible for the appropriate surveillance.  It simply has to know the applicable requirements relating to the devices it has certified. 

    I take "all of the applicable requirements" to mean all of the requirements applicable to the MDD certification.  There are most likely requirements applicable to these devices under other laws and regulations.  I don't think this language means the notified body that issued the MDD certificate is responsible for appropriate surveillance of the requirements applicable to the device under the MDR than it is for the requirements under any other laws or regulations that might apply to the device. 

    I think no one is going to be responsible for appropriate surveillance of the requirements applicable to these devices during the transition period.  Unless the EU had a lot patients being injured or killed by unsafe Class I devices marketed under the MDD (which of course it could have, and we would not know), this lack of oversight for a few years would not keep me up nights. At least, no more than it would have when the lack of oversight was due to a lack of requirements to oversee.

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 26.  RE: Input needed from MDR gurus!

    Posted 24-Jan-2020 19:21

    Let me clarify the situation.

    On the date of application of the MDR, the MDD does not become void. It will live on for many years.

    In the MDR Article 120(1) it is the notification of the NB that becomes void. This means there will be no new MDD NBs nor new device certificates to the MDD.

    Article 120(3)(second paragraph) says that the NB that issued the certificate is responsible for surveillance.

    So, when the NB conducts surveillance what are the requirements? The answer is in Article 120(3). The manufacturer must comply with the MDD except for (as enumerated):
    No significant design changes
    No significant intended use changes
    Post-market surveillance from the MDR, not the MDD
    Market surveillance from the MDR, not the MDD
    Vigilance from the MDR, not the MDD
    Economic operator registration from the MDR, not the MDD
    Device registration from the MDR, not the MDD

    As a result, the device is not fully compliant with the MDD. Also, the device is not fully compliant with the MDR. It is compliant with a hybrid, the MDD as modified by MDR Article 120. The DoC must be correct, so it must state the hybrid state.



    ------------------------------
    Dan O'Leary CQA, CQE
    Swanzey NH
    United States
    ------------------------------



  • 27.  RE: Input needed from MDR gurus!

    Posted 24-Jan-2020 20:01
    Edited by Julie Omohundro 24-Jan-2020 22:05
    When all else fails....

    Article 120 Transitional provisions

    1.From 26 May 2020, any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void.

    Article 122 Repeal

    Without prejudice to Articles 120(3) and (4) of this Regulation, and without prejudice to the obligations of the Member States and manufacturers as regards vigilance and to the obligations of manufacturers as regards the making available of documentation, under Directives 90/385/EEC and 93/42/EEC, those Directives are repealed with effect from 26 May 2020, with the exception of:

     - Articles 8 and 10, points (b) and (c) of Article 10b(1), Article 10b(2) and Article 10b(3) of Directive 90/385/EEC, and the obligations relating to vigilance and clinical investigations provided for in the corresponding Annexes, which are repealed with effect from the later of the dates referred to in point (d) of Article 123(3) of this Regulation;

    - Article 10a and point (a) of Article 10b(1) of Directive 90/385/EEC, and the obligations relating to registration of devices and economic operators, and to certificate notifications, provided for in the corresponding Annexes, which are repealed with effect from 18 months after the later of the dates referred to in point (d) of Article 123(3) of this Regulation;

    - Article 10, points (c) and (d) of Article 14a(1), Article 14a(2), Article 14a(3) and Article 15 of Directive 93/42/EEC, and the obligations relating to vigilance and clinical investigations provided for in the corresponding Annexes, which are repealed with effect from the later of the dates referred to in point (d) of Article 123(3) of this Regulation; and 5.5.2017 L 117/90 Official Journal of the European Union EN

    - Article 14(1) and (2) and points (a) and (b) of Article 14a(1) of Directive 93/42/EEC, and the obligations relating to registration of devices and economic operators, and to certificate notifications, provided for in the corresponding Annexes, which are repealed with effect from 18 months after the later of the dates referred to in point (d) of Article 123(3) of this Regulation.

    As regards the devices referred to in Article 120 (3) and (4) of this Regulation, the Directives referred to in the first paragraph shall continue to apply until 27 May 2025 to the extent necessary for the application of those paragraphs.

    I am not sure this covers all applicable text, but I find things can sometimes get more confusing when people quote snippets in the interest of brevity.

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 28.  RE: Input needed from MDR gurus!

    Posted 25-Jan-2020 04:26
    HI Peter, just a precision. I was speaking about software devices and the consensus opinion over the past three years has been that all software devices are now IIa under the MDR. Hence, with all the startups developing software devices, we decided on the strategy/deadline of self certifying to class I MDD before May this year. That way they could at least launch their products in the EU and have a couple of years space (using Art. 120) to see how the whole software devices story plays out.
    Regards

    ------------------------------
    Kevin Painter
    Mentor, Medical Device Regulatory Compliance
    Poland and United Kingdom
    ------------------------------



  • 29.  RE: Input needed from MDR gurus!

    Posted 25-Jan-2020 11:15
    Yes, I'm very interested to see how "the whole software devices story" plays out.  The MDR is almost certain to have an impact on that story, but I think it will not determine the whole story, because, like so many stories these days, that story is a global one.

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 30.  RE: Input needed from MDR gurus!

    This message was posted by a user wishing to remain anonymous
    Posted 24-Jan-2020 09:57
    This message was posted by a user wishing to remain anonymous

    ​Can anyone think of any reason why a lot of Class I devices should come off the EU market May 26?  

    • Some companies may give up on the European market altogether, if they don't have a lot of sales there, not wanting to accept the increased costs, increased liability, required transparency, etc.
    • Some companies don't have the will to implement all the new requirements on time, and may withdraw temporarily.
    • Some companies may want to stay in the market, but be refused by their former authorized reps. The EC REPs have more liability under the MDR if they accept products with inadequate documentation.

    Companies with well-implemented MDD conformity have a hard enough time updating to MDR processes. For those manufacturers of Class I devices whose conformity was always a little half-baked, it's a major change.


  • 31.  RE: Input needed from MDR gurus!

    Posted 24-Jan-2020 10:33
    I agree with all of these reasons why some number (not small, but not sure how big) of Class I devices WILL come off the EU market.  Opinions will vary as to whether Class I devices that come off the EU market "should" come off of the EU market or not. 

    I also agree with the last statement, except I would say "have had a hard enough time," as I do not think a hard time is inherent in the MDR. 


    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------



  • 32.  RE: Input needed from MDR gurus!

    This message was posted by a user wishing to remain anonymous
    Posted 04-Mar-2020 12:46
    This message was posted by a user wishing to remain anonymous

    Can anyone confirm whether an MDD-certified device can remain on the market after May 26 without an MDD-designated NB continuing to provide regulatory oversight services, including audits?


  • 33.  RE: Input needed from MDR gurus!

    Posted 05-Mar-2020 02:29
    Yes, it can. See my answer in a post close by this one.
    In the ​FAQ document published in early 201 by CAMD it is confirmed that Notified Bodies which issued the certificates will continue to be responsible for the appropriate surveillance (and therefor to handle changes), despite their designation under MDD/AIMDD becoming void on May 26th. Notified Bodies will have this task regardless of whether or not they have applied for an MDR designation (MDCG 2019-10).

    ------------------------------
    Peter Reijntjes
    Principal Consultant Regulatory & Quality Affairs
    Arnhem
    Netherlands
    ------------------------------



  • 34.  RE: Input needed from MDR gurus!

    Posted 05-Mar-2020 09:55
    Peter, thanks.  The "anonymous" post above is mine, must have accidentally clicked on that checkbox, which is located right next to Send. I reposted the question to this thread after not getting any responses to the first one.  (A question gets more visibility when you post it as its own discussion, but I think comments are sent directly to all thread participants, so sometimes I prefer a comment, when a thread seems to have attracted a lot of people with expertise related to my question. As did this one.)

    Thanks for confirming.  It seemed like everyone was mentioning this requirement for the transition until Corrigendum 2 came along, and no one seemed to be mentioning it any more.  I started wondering if Corrigendum 2 might have eliminated this requirement in a way that escaped me. 

    Maybe people just gave up trying to list all the requirements in one breath, as the list seems to get longer and longer.  Fairly recently someone posted a list of three "Must haves" by May 26, which I think reflected the exhaustion that has started to set in.

    Now, if you have any experience with "clinical evidence not deemed appropriate," I'd be pleased to have your comment in that thread as well!

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Mebane, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------